MeSH term
Frequency | Condition_Probility | Female | 44 | 0.0 |
Humans | 361 | 0.0 |
Pregnancy | 13 | 0.0 |
Animals | 176 | 0.0 |
CHO Cells | 5 | 0.0 |
Genetic Vectors | 10 | 0.0 |
Half-Life | 4 | 0.0 |
Hamsters | 7 | 0.0 |
Hela Cells | 48 | 0.0 |
Proteins/metabolism | 2 | 0.0 |
RNA Stability | 2 | 3.0 |
RNA, Messenger/metabolism | 27 | 0.0 |
Research Support, Non-U.S. Gov't | 238 | 0.0 |
*Transcription, Genetic | 38 | 1.0 |
Transfection | 107 | 0.0 |
Amino Acid Motifs | 7 | 0.0 |
Base Sequence | 192 | 0.0 |
Binding Sites | 101 | 1.0 |
Binding, Competitive | 16 | 0.0 |
Blotting, Northern | 16 | 0.0 |
Blotting, Western | 25 | 0.0 |
COS Cells | 10 | 0.0 |
Cell Differentiation | 12 | 0.0 |
Cell Nucleus/metabolism | 29 | 1.0 |
Cells, Cultured | 57 | 0.0 |
DNA/*metabolism | 4 | 0.0 |
DNA-Binding Proteins/*metabolism | 63 | 3.0 |
Drosophila | 25 | 8.0 |
*Enhancer Elements (Genetics) | 7 | 2.0 |
Fibroblasts/metabolism | 6 | 0.0 |
Genes, Reporter | 49 | 2.0 |
Immunoblotting | 7 | 0.0 |
Mice | 71 | 0.0 |
Molecular Sequence Data | 176 | 0.0 |
Mutation | 34 | 0.0 |
Oligonucleotides/metabolism | 6 | 8.0 |
Plasmids/metabolism | 16 | 1.0 |
Protein Binding | 74 | 0.0 |
Rats | 38 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 162 | 0.0 |
Transcription Factor, Sp1/*metabolism | 72 | 19.0 |
Transcription Factors/*metabolism | 71 | 4.0 |
Cell Division | 5 | 0.0 |
Chromatin/metabolism | 10 | 3.0 |
DNA-Binding Proteins/metabolism | 53 | 2.0 |
Enzyme Activation | 3 | 0.0 |
Enzyme Inhibitors/pharmacology | 11 | 0.0 |
Gene Expression Regulation | 37 | 1.0 |
*Gene Silencing | 4 | 2.0 |
Histones/metabolism | 4 | 1.0 |
Hydroxamic Acids/pharmacology | 9 | 5.0 |
Macromolecular Substances | 4 | 0.0 |
Precipitin Tests | 12 | 0.0 |
Promoter Regions (Genetics) | 91 | 2.0 |
RNA Polymerase II/metabolism | 3 | 2.0 |
Repressor Proteins/*metabolism | 4 | 2.0 |
Reverse Transcriptase Polymerase Chain Reaction | 14 | 0.0 |
Time Factors | 12 | 0.0 |
Transcription Factor, Sp1/metabolism | 51 | 15.0 |
Transcription Factors/metabolism | 45 | 3.0 |
Tumor Cells, Cultured | 84 | 0.0 |
Adult | 16 | 0.0 |
Middle Aged | 10 | 0.0 |
Phosphorylation/drug effects | 2 | 0.0 |
Promoter Regions (Genetics)/*genetics | 29 | 3.0 |
Protein Structure, Tertiary | 11 | 0.0 |
Recombinant Fusion Proteins/physiology | 3 | 1.0 |
Regulatory Sequences, Nucleic Acid | 16 | 2.0 |
*Trans-Activation (Genetics) | 17 | 2.0 |
Transcription Factor, Sp1/*physiology | 27 | 31.0 |
Carcinoma, Squamous Cell | 2 | 1.0 |
DNA Primers | 17 | 0.0 |
Flavonoids/pharmacology | 2 | 0.0 |
Lung Neoplasms | 2 | 1.0 |
Polymerase Chain Reaction | 15 | 0.0 |
Insulin-Like Growth Factor I/*physiology | 2 | 5.0 |
Cell Line | 85 | 0.0 |
*Immediate-Early Proteins | 12 | 5.0 |
*Promoter Regions (Genetics) | 109 | 4.0 |
Sequence Alignment | 21 | 0.0 |
Zinc Fingers | 12 | 2.0 |
Amino Acid Sequence | 22 | 0.0 |
CpG Islands | 5 | 1.0 |
DNA Methylation | 9 | 1.0 |
*Drosophila Proteins | 3 | 0.0 |
*Gene Expression Regulation | 28 | 1.0 |
Membrane Glycoproteins/*genetics | 3 | 0.0 |
NF-kappa B/metabolism | 8 | 1.0 |
RNA, Messenger/analysis | 6 | 0.0 |
Catalysis | 2 | 0.0 |
Dose-Response Relationship, Drug | 9 | 0.0 |
Gene Deletion | 20 | 1.0 |
Gene Expression Regulation, Enzymologic | 10 | 1.0 |
Genes, Dominant | 2 | 0.0 |
Luciferases/metabolism | 23 | 3.0 |
Mutagenesis, Site-Directed | 44 | 1.0 |
Proto-Oncogene Proteins c-jun/*metabolism | 2 | 2.0 |
Tetradecanoylphorbol Acetate/pharmacology | 13 | 0.0 |
Trans-Activators/*metabolism | 3 | 0.0 |
Binding Sites/genetics | 32 | 3.0 |
DNA/genetics/metabolism | 13 | 3.0 |
DNA-Binding Proteins/genetics/metabolism | 12 | 2.0 |
Luciferases/genetics | 14 | 4.0 |
Transcription Factor, Sp1/genetics/metabolism | 13 | 39.0 |
Transcription Factors/genetics/metabolism | 16 | 3.0 |
Transcription, Genetic | 81 | 1.0 |
Connexins/*genetics | 3 | 1.0 |
Electrophoretic Mobility Shift Assay | 21 | 4.0 |
Male | 31 | 0.0 |
Rats, Wistar | 2 | 0.0 |
Response Elements | 8 | 3.0 |
Cell Division/physiology | 2 | 0.0 |
DNA-Binding Proteins/physiology | 9 | 3.0 |
Gene Expression Regulation, Neoplastic | 8 | 0.0 |
RNA, Messenger/biosynthesis/genetics | 4 | 0.0 |
Transcription Factor, Sp1/physiology | 8 | 21.0 |
Transcription Factors/*physiology | 30 | 6.0 |
Algorithms | 2 | 0.0 |
Comparative Study | 26 | 0.0 |
ROC Curve | 2 | 1.0 |
Cell Culture Techniques | 3 | 0.0 |
Cloning, Molecular | 31 | 0.0 |
DNA/metabolism | 21 | 1.0 |
DNA Footprinting | 18 | 6.0 |
DNA-Binding Proteins/metabolism/*pharmacology | 2 | 33.0 |
Deoxyribonuclease I | 2 | 1.0 |
Exons | 8 | 0.0 |
Gene Expression Regulation/*drug effects | 5 | 0.0 |
Restriction Mapping | 9 | 0.0 |
Sertoli Cells/*metabolism | 2 | 20.0 |
Transcription Factor, Sp1/metabolism/*pharmacology | 2 | 40.0 |
Transcription, Genetic/drug effects | 5 | 0.0 |
DNA-Binding Proteins/*physiology | 26 | 5.0 |
RNA/metabolism | 5 | 1.0 |
5' Flanking Region/genetics | 7 | 8.0 |
Chloramphenicol O-Acetyltransferase/genetics/metabolism | 3 | 1.0 |
Cytochrome P-450 Enzyme System/*genetics | 4 | 0.0 |
*DNA-Binding Proteins | 5 | 0.0 |
Deoxyribonuclease I/metabolism | 5 | 3.0 |
Recombinant Fusion Proteins/genetics/metabolism | 13 | 1.0 |
Sequence Deletion | 25 | 1.0 |
Conserved Sequence | 7 | 0.0 |
Multigene Family | 6 | 0.0 |
Phylogeny | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 6 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 20 | 0.0 |
Species Specificity | 6 | 0.0 |
Zinc Fingers/genetics | 5 | 2.0 |
DNA | 12 | 1.0 |
Hydroxysteroid Dehydrogenases/*genetics | 2 | 11.0 |
DNA, Complementary | 3 | 0.0 |
*Regulatory Sequences, Nucleic Acid | 3 | 0.0 |
Transcription, Genetic/physiology | 4 | 2.0 |
Sequence Homology, Nucleic Acid | 25 | 0.0 |
Glutathione Transferase/metabolism | 4 | 0.0 |
Plasmids | 10 | 0.0 |
Transcription Factors/*genetics/metabolism | 7 | 2.0 |
Nucleic Acid Conformation | 2 | 0.0 |
Proteolipids/*genetics | 2 | 20.0 |
Pulmonary Surfactants/*genetics | 2 | 15.0 |
Trans-Activation (Genetics) | 33 | 2.0 |
Acetylation | 5 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 22 | 2.0 |
Gene Expression | 7 | 0.0 |
Point Mutation | 6 | 0.0 |
Recombinant Proteins/genetics/metabolism | 6 | 0.0 |
Trans-Activators/genetics/metabolism | 3 | 1.0 |
Transcription Factors/genetics/*metabolism | 21 | 2.0 |
3T3 Cells | 14 | 0.0 |
Base Sequence/genetics | 6 | 1.0 |
DNA-Binding Proteins/genetics | 7 | 0.0 |
Promoter Regions (Genetics)/physiology | 6 | 3.0 |
Aged | 7 | 0.0 |
Protein Synthesis Inhibitors/pharmacology | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 9 | 0.0 |
Transcription, Genetic/*drug effects | 4 | 1.0 |
Vascular Endothelial Growth Factor A | 2 | 0.0 |
Vascular Endothelial Growth Factors | 2 | 0.0 |
Disease Models, Animal | 2 | 0.0 |
Lipoprotein Lipase/*genetics | 2 | 1.0 |
Protein-Serine-Threonine Kinases/metabolism | 3 | 0.0 |
RNA, Messenger/genetics | 6 | 0.0 |
Transcription, Genetic/*physiology | 9 | 4.0 |
DNA-Binding Proteins/*pharmacology | 2 | 5.0 |
Plicamycin/pharmacology | 7 | 43.0 |
Promoter Regions (Genetics)/drug effects | 3 | 2.0 |
Transcription Factor, Sp1/*pharmacology | 2 | 40.0 |
Transcription Factors/*pharmacology | 2 | 8.0 |
Transcription Initiation Site | 9 | 6.0 |
DNA-Binding Proteins/*genetics/*metabolism | 3 | 2.0 |
Insects | 2 | 1.0 |
Protein Biosynthesis | 6 | 0.0 |
Protein Isoforms | 5 | 0.0 |
Sequence Analysis, DNA | 15 | 0.0 |
Tetrahydrofolate Dehydrogenase/genetics | 2 | 2.0 |
Transcription Factors/*genetics/*metabolism | 3 | 2.0 |
CCAAT-Binding Factor/*metabolism | 2 | 12.0 |
Cathepsins/*genetics | 2 | 8.0 |
Carcinoma, Hepatocellular | 4 | 1.0 |
GC Rich Sequence/*physiology | 2 | 66.0 |
Genes, Regulator | 2 | 1.0 |
Trans-Activation (Genetics)/physiology | 2 | 2.0 |
Carrier Proteins/*genetics | 6 | 0.0 |
Luciferases/genetics/metabolism | 15 | 7.0 |
*Membrane Proteins | 4 | 0.0 |
*Saccharomyces cerevisiae Proteins | 4 | 0.0 |
GC Rich Sequence | 2 | 9.0 |
*Polymorphism, Single Nucleotide | 2 | 0.0 |
Nuclear Proteins/metabolism | 18 | 2.0 |
Protein Binding/drug effects | 3 | 0.0 |
Regulatory Sequences, Nucleic Acid/genetics | 4 | 5.0 |
Enhancer Elements (Genetics) | 4 | 1.0 |
Transcription Factor AP-1/genetics/*metabolism | 3 | 11.0 |
Transcription Factor, Sp1/genetics/*metabolism | 25 | 32.0 |
Cell Line, Transformed | 6 | 0.0 |
DNA/chemistry/genetics/metabolism | 2 | 4.0 |
Caco-2 Cells | 5 | 1.0 |
*Chemokines, CXC | 2 | 3.0 |
Epithelial Cells/metabolism | 4 | 1.0 |
Transcription Factor, Sp1/genetics/*physiology | 5 | 45.0 |
Gene Frequency | 2 | 0.0 |
Genotype | 2 | 0.0 |
Linkage Disequilibrium | 2 | 0.0 |
Promoter Regions (Genetics)/genetics | 21 | 1.0 |
Butyrates/*pharmacology | 5 | 11.0 |
Histone Deacetylases/*antagonists & inhibitors | 6 | 12.0 |
Insulin-Like Growth Factor Binding Protein 3/*genetics | 2 | 15.0 |
Chromosome Mapping | 5 | 0.0 |
Collagen/*genetics | 5 | 1.0 |
GC Rich Sequence/genetics | 2 | 9.0 |
Infant | 3 | 0.0 |
Nuclear Proteins/genetics | 2 | 0.0 |
Phosphorylation | 12 | 0.0 |
Receptors, Cytoplasmic and Nuclear/metabolism | 2 | 1.0 |
DNA-Binding Proteins/metabolism/*physiology | 4 | 3.0 |
Gene Expression Regulation, Enzymologic/*physiology | 3 | 3.0 |
NF-kappa B/*metabolism | 2 | 0.0 |
Transcription Factors/metabolism/*physiology | 5 | 5.0 |
Child | 4 | 0.0 |
DNA Probes | 3 | 0.0 |
Jurkat Cells | 11 | 0.0 |
T-Lymphocytes | 4 | 1.0 |
*Polymorphism, Genetic | 2 | 0.0 |
CpG Islands/genetics | 2 | 1.0 |
DNA/genetics | 2 | 0.0 |
Transcription Factor, Sp1/metabolism/*physiology | 4 | 26.0 |
Adrenal Gland Neoplasms | 2 | 12.0 |
DNA/chemistry/metabolism | 2 | 2.0 |
Liver Neoplasms | 3 | 1.0 |
Structure-Activity Relationship | 5 | 0.0 |
Cell Differentiation/physiology | 3 | 0.0 |
Models, Genetic | 11 | 0.0 |
Recombinant Proteins/metabolism | 8 | 0.0 |
Breast Neoplasms | 3 | 1.0 |
Colonic Neoplasms | 2 | 1.0 |
Gene Expression Regulation/drug effects/*physiology | 2 | 2.0 |
Gene Expression Regulation, Neoplastic/*drug effects | 5 | 1.0 |
Protein-Serine-Threonine Kinases/*genetics | 2 | 0.0 |
DNA Mutational Analysis | 13 | 0.0 |
DNA, Complementary/metabolism | 5 | 0.0 |
*Gene Expression Regulation, Enzymologic | 16 | 3.0 |
*Transcription Factors | 2 | 0.0 |
*Chromosome Mapping | 3 | 0.0 |
Consensus Sequence | 8 | 1.0 |
Genomic Library | 4 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
*Gene Expression Regulation, Neoplastic | 4 | 0.0 |
Protein Kinase C/physiology | 2 | 1.0 |
TATA Box | 6 | 1.0 |
Transcription Factors/physiology | 5 | 2.0 |
Gelatinase A/*genetics | 2 | 22.0 |
Nuclear Proteins/*physiology | 2 | 1.0 |
DNA-Binding Proteins/genetics/physiology | 2 | 2.0 |
Electrophoresis, Polyacrylamide Gel | 10 | 0.0 |
Transcription Factors/genetics/physiology | 2 | 3.0 |
Genes, Reporter/genetics | 3 | 1.0 |
Lipopolysaccharides/pharmacology | 2 | 0.0 |
Mice, Inbred C57BL | 5 | 0.0 |
Trans-Activators/genetics/*metabolism | 3 | 0.0 |
Oxidation-Reduction | 2 | 0.0 |
Signal Transduction | 4 | 0.0 |
U937 Cells | 3 | 0.0 |
Cell Extracts | 3 | 2.0 |
Gene Expression Regulation, Viral | 3 | 1.0 |
K562 Cells | 6 | 1.0 |
Response Elements/genetics | 6 | 3.0 |
DNA Primers/genetics | 2 | 0.0 |
Pregnancy Proteins/metabolism | 2 | 12.0 |
*RNA | 2 | 6.0 |
Telomerase/*genetics/metabolism | 4 | 20.0 |
Gene Expression Regulation/*genetics | 4 | 2.0 |
Mammary Glands, Animal/*metabolism | 2 | 10.0 |
*Gene Expression Regulation, Viral | 3 | 1.0 |
Herpesvirus 4, Human/*genetics | 3 | 4.0 |
Trans-Activators/*genetics | 8 | 2.0 |
Cell Line, Tumor | 28 | 0.0 |
Transcription Factor, Sp1/*genetics | 7 | 16.0 |
Down-Regulation | 8 | 0.0 |
Organ Specificity | 7 | 0.0 |
Thymidine Kinase/genetics | 3 | 3.0 |
Gene Expression Regulation, Developmental | 3 | 0.0 |
Rats, Sprague-Dawley | 10 | 0.0 |
Cercopithecus aethiops | 7 | 0.0 |
Islets of Langerhans/*metabolism | 3 | 5.0 |
Nuclear Proteins/*metabolism | 4 | 0.0 |
Brain/*metabolism | 2 | 0.0 |
Electrophoresis/methods | 3 | 3.0 |
*Gene Expression Regulation/drug effects | 6 | 3.0 |
Trans-Activators/metabolism | 5 | 0.0 |
Transcription Factors/*metabolism/pharmacology | 2 | 18.0 |
5' Untranslated Regions | 2 | 1.0 |
Antigens, CD/*genetics | 2 | 0.0 |
Integrin alpha2 | 2 | 10.0 |
Leukocytes, Mononuclear/metabolism | 2 | 0.0 |
Transcription, Genetic/genetics | 2 | 0.0 |
DNA Primers/chemistry | 5 | 0.0 |
Drosophila melanogaster | 6 | 5.0 |
Cattle | 7 | 0.0 |
Gene Expression Regulation, Enzymologic/*drug effects | 2 | 1.0 |
Gene Expression Regulation/drug effects | 14 | 1.0 |
Mice, Inbred Strains | 3 | 0.0 |
DNA/chemistry | 2 | 0.0 |
Protein Processing, Post-Translational | 3 | 0.0 |
Introns | 5 | 0.0 |
Up-Regulation | 12 | 0.0 |
DNA, Neoplasm/metabolism | 2 | 1.0 |
Enzyme Inhibitors/*pharmacology | 4 | 0.0 |
Hydroxamic Acids/*pharmacology | 3 | 6.0 |
Recombinant Fusion Proteins/genetics | 2 | 1.0 |
Tumor Cells, Cultured/drug effects | 2 | 0.0 |
*Repressor Proteins | 4 | 0.0 |
*Membrane Transport Proteins | 3 | 0.0 |
Gene Expression Regulation, Enzymologic/genetics | 2 | 3.0 |
Cyclins/*genetics | 6 | 4.0 |
Drosophila/cytology | 5 | 41.0 |
Kinetics | 8 | 0.0 |
Nuclear Proteins/genetics/*metabolism | 2 | 0.0 |
Collagen/genetics | 2 | 2.0 |
Gene Expression/drug effects | 3 | 0.0 |
Scleroderma, Systemic/*metabolism/*pathology | 2 | 40.0 |
Oligonucleotide Probes | 5 | 0.0 |
Promoter Regions (Genetics)/drug effects/genetics | 2 | 6.0 |
*Introns | 2 | 0.0 |
Retinoid X Receptors | 2 | 0.0 |
Transcription Factors/genetics/metabolism/physiology | 2 | 33.0 |
Tretinoin/*metabolism/pharmacology | 2 | 11.0 |
Aldehyde Oxidoreductases/*genetics | 2 | 11.0 |
Recombinant Fusion Proteins | 2 | 0.0 |
Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors/metabolism | 2 | 8.0 |
Mutagenesis | 9 | 0.0 |
Receptors, Estrogen/*metabolism | 2 | 0.0 |
Signal Transduction/drug effects | 2 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Lung/*metabolism | 3 | 3.0 |
Glutathione Transferase/*genetics | 3 | 0.0 |
Electrophoresis | 3 | 1.0 |
Myocardium/metabolism | 2 | 0.0 |
Adenovirus E1A Proteins/metabolism | 2 | 6.0 |
Cell Cycle Proteins/*metabolism | 3 | 0.0 |
Repressor Proteins/metabolism | 2 | 1.0 |
*CCAAT-Enhancer-Binding Proteins | 5 | 3.0 |
DNA-Binding Proteins/*genetics/metabolism | 7 | 1.0 |
Nuclear Proteins/*genetics/metabolism | 2 | 1.0 |
Transcription Factor, Sp1/*genetics/metabolism | 6 | 28.0 |
Sequence Homology, Amino Acid | 6 | 0.0 |
Transcription Factors | 2 | 2.0 |
Prostate/*enzymology | 3 | 2.0 |
CCAAT-Enhancer-Binding Proteins | 3 | 1.0 |
Cyclic AMP/*metabolism | 2 | 0.0 |
Drug Synergism | 3 | 0.0 |
Models, Molecular | 5 | 0.0 |
Recombinant Fusion Proteins/biosynthesis | 13 | 3.0 |
Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
Sodium Channels/*genetics | 2 | 2.0 |
*Proto-Oncogene Proteins | 3 | 0.0 |
Promoter Regions (Genetics)/genetics/*physiology | 3 | 11.0 |
Rabbits | 6 | 0.0 |
Estradiol/pharmacology | 2 | 0.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
*Transcription, Genetic/drug effects | 2 | 1.0 |
Proto-Oncogene Proteins/*metabolism | 2 | 0.0 |
Binding Sites/physiology | 2 | 1.0 |
*Glycoproteins | 2 | 0.0 |
Transcription Factors/genetics | 5 | 0.0 |
Cytosine | 2 | 2.0 |
*Cell Cycle Proteins | 6 | 0.0 |
*Tumor Suppressor Proteins | 2 | 0.0 |
Mice, Transgenic | 5 | 0.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/metabolism | 2 | 1.0 |
Mutation/genetics | 2 | 0.0 |
Response Elements/*genetics | 2 | 3.0 |
Transcription, Genetic/*genetics | 3 | 1.0 |
Adenocarcinoma | 2 | 1.0 |
Base Composition | 5 | 1.0 |
Gastrins/*genetics | 2 | 18.0 |
Recombinant Fusion Proteins/biosynthesis/metabolism | 2 | 2.0 |
Stomach Neoplasms | 2 | 6.0 |
Genetic Complementation Test | 2 | 0.0 |
In Vitro | 4 | 0.0 |
Promoter Regions (Genetics)/*physiology | 2 | 2.0 |
Evolution, Molecular | 2 | 0.0 |
Transcription Factors/chemistry/genetics/*metabolism | 4 | 2.0 |
DNA-Binding Proteins/*genetics | 11 | 0.0 |
Transcription Factors/*genetics | 10 | 0.0 |
Enhancer Elements (Genetics)/genetics | 2 | 2.0 |
Transcription Factor, Sp1/genetics | 4 | 10.0 |
Choriocarcinoma | 2 | 5.0 |
Chloramphenicol O-Acetyltransferase/genetics | 2 | 0.0 |
Animals, Newborn | 5 | 0.0 |
Gene Expression Regulation/genetics | 3 | 1.0 |
Trans-Activation (Genetics)/*genetics | 4 | 4.0 |
Cyclins/*genetics/metabolism | 4 | 8.0 |
Nuclear Proteins/genetics/metabolism | 2 | 1.0 |
Cell Nucleus/chemistry | 3 | 1.0 |
Infant, Newborn | 2 | 0.0 |
Interferon-alpha/pharmacology | 2 | 2.0 |
Apoptosis | 3 | 0.0 |
Transcription Factors/chemistry/*metabolism | 3 | 2.0 |
Yeasts/genetics | 2 | 2.0 |
*Zinc Fingers | 6 | 2.0 |
Azacitidine/pharmacology | 2 | 4.0 |
*DNA Methylation | 4 | 0.0 |
Proto-Oncogene Proteins/metabolism | 4 | 0.0 |
Sulfites/pharmacology | 3 | 9.0 |
Oligonucleotides/pharmacology | 2 | 5.0 |
Fungal Proteins/metabolism | 2 | 1.0 |
Gene Expression Regulation/*physiology | 3 | 0.0 |
Endothelium, Vascular/enzymology | 2 | 4.0 |
Mutagenesis, Insertional | 3 | 1.0 |
Nitric-Oxide Synthase/*genetics | 2 | 2.0 |
Chorionic Gonadotropin/pharmacology | 3 | 2.0 |
Genes, Regulator/*genetics | 2 | 4.0 |
Transfection/genetics | 2 | 1.0 |
Adolescent | 6 | 0.0 |
Analysis of Variance | 2 | 0.0 |
*Brain Mapping | 3 | 6.0 |
Electroencephalography | 2 | 0.0 |
Pain/*physiopathology | 2 | 6.0 |
8-Bromo Cyclic Adenosine Monophosphate/pharmacology | 2 | 2.0 |
Forskolin/pharmacology | 3 | 0.0 |
Glycoproteins/*genetics | 2 | 1.0 |
DNA, Viral | 3 | 1.0 |
Ionomycin/pharmacology | 2 | 0.0 |
*Viral Proteins | 3 | 1.0 |
Helix-Loop-Helix Motifs | 2 | 0.0 |
Chromosome Banding | 2 | 0.0 |
*Chromosomes, Human, Pair 17 | 2 | 0.0 |
Transcription Factor, Sp1/genetics/metabolism/*physiology | 2 | 28.0 |
Receptor Protein-Tyrosine Kinases/*genetics | 2 | 0.0 |
*Multigene Family | 3 | 0.0 |
HIV Long Terminal Repeat/*genetics | 3 | 4.0 |
Protein Binding/genetics | 4 | 1.0 |
*Carrier Proteins | 2 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Retinoblastoma Protein/metabolism | 2 | 0.0 |
DNA-Binding Proteins/genetics/*physiology | 2 | 0.0 |
Transcription Factors/genetics/*physiology | 3 | 1.0 |
Transforming Growth Factor beta/*pharmacology | 2 | 0.0 |
Endothelium, Vascular/cytology/*metabolism | 2 | 1.0 |
Luciferases/biosynthesis | 2 | 2.0 |
Transcription Factor, Sp1/biosynthesis/*metabolism | 2 | 40.0 |
Umbilical Veins | 2 | 0.0 |
Nerve Tissue Proteins/*genetics | 2 | 0.0 |
Keratinocytes/*metabolism | 3 | 3.0 |
Protein Conformation | 2 | 0.0 |
Brain/metabolism | 2 | 0.0 |
Liver/metabolism | 2 | 0.0 |
Templates, Genetic | 2 | 1.0 |
5' Flanking Region | 3 | 5.0 |
*CpG Islands | 2 | 2.0 |
Drosophila/cytology/genetics | 3 | 75.0 |
*TATA Box | 3 | 2.0 |
DNA, Viral/metabolism | 2 | 2.0 |
Antineoplastic Agents/*pharmacology | 2 | 0.0 |
*Down-Regulation | 4 | 1.0 |
Repetitive Sequences, Nucleic Acid/*genetics | 2 | 1.0 |
Gene Products, tax/*metabolism | 3 | 9.0 |
Human T-lymphotropic virus 1/*metabolism | 2 | 10.0 |
Luciferases | 2 | 5.0 |
Oligodeoxyribonucleotides | 6 | 0.0 |
Platelet-Derived Growth Factor/*biosynthesis/genetics | 2 | 50.0 |
Proto-Oncogene Proteins/*biosynthesis/genetics | 2 | 2.0 |
Proto-Oncogene Proteins c-sis | 4 | 17.0 |
Binding Sites/genetics/physiology | 2 | 11.0 |
Membrane Proteins/*genetics | 3 | 0.0 |
Cell Cycle | 2 | 0.0 |
Azacitidine/*analogs & derivatives/pharmacology | 3 | 4.0 |
Chondrocytes/metabolism | 2 | 5.0 |
Cytosine/metabolism | 4 | 11.0 |
RNA Interference | 2 | 0.0 |
RNA, Small Interfering/metabolism | 2 | 1.0 |
Collagen/*genetics/metabolism | 2 | 5.0 |
HL-60 Cells | 3 | 0.0 |
Transcription Factor AP-1/metabolism | 3 | 1.0 |
Transforming Growth Factor beta/*metabolism | 2 | 0.0 |
Chloramphenicol O-Acetyltransferase/biosynthesis | 2 | 1.0 |
Glycolysis | 2 | 3.0 |
Myocardium/*metabolism | 2 | 0.0 |
Codon | 2 | 0.0 |
Antibodies/immunology/metabolism | 2 | 11.0 |
Cross-Linking Reagents/metabolism | 2 | 3.0 |
*Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
Drosophila melanogaster/cytology | 2 | 28.0 |
Phenotype | 2 | 0.0 |
Cell Division/drug effects | 2 | 0.0 |
Transcription Factor, Sp1/*biosynthesis/genetics | 2 | 50.0 |
Transcription Factors/*biosynthesis/genetics | 2 | 2.0 |
Electric Stimulation | 2 | 0.0 |
RNA, Messenger | 2 | 0.0 |
DNA-Binding Proteins/chemistry/*metabolism | 2 | 1.0 |
Proteins/*genetics | 2 | 0.0 |
Proto-Oncogene Proteins/*genetics | 2 | 0.0 |
*Genes, myc | 2 | 0.0 |
*Intercellular Signaling Peptides and Proteins | 2 | 0.0 |
Trans-Activators/*physiology | 2 | 0.0 |
Chloramphenicol O-Acetyltransferase/metabolism | 3 | 2.0 |
Calibration | 2 | 1.0 |
Child, Preschool | 2 | 0.0 |
Reference Standards | 2 | 0.0 |
World Health Organization | 2 | 2.0 |
Protein Transport | 2 | 0.0 |
Transcription Factors/chemistry/*physiology | 2 | 5.0 |
I-kappa B/metabolism | 2 | 2.0 |
*Up-Regulation | 2 | 0.0 |
Brain/*physiology | 2 | 1.0 |
Evoked Potentials, Somatosensory/*physiology | 2 | 7.0 |
Pain/physiopathology | 2 | 9.0 |
Reaction Time/physiology | 2 | 2.0 |
Sural Nerve/*physiology | 2 | 33.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Signal Transduction/physiology | 2 | 0.0 |
Software | 2 | 0.0 |
DNA-Binding Proteins/*chemistry | 2 | 2.0 |
Transcription Factors/*chemistry | 2 | 4.0 |
Organ Specificity/genetics | 2 | 1.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Enhancer Elements (Genetics)/*genetics | 2 | 2.0 |
Oligonucleotides/genetics/metabolism | 5 | 15.0 |
Interferon Type II/pharmacology | 2 | 0.0 |
Estrogen Receptor alpha | 2 | 0.0 |
Acetyltransferases/metabolism | 2 | 2.0 |
Endothelium, Vascular/*cytology | 2 | 1.0 |
Protein p53/metabolism | 2 | 0.0 |
Amino Acid Sequence/genetics | 2 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
English Abstract | 7 | 0.0 |
Pregnancy/*immunology | 2 | 3.0 |
Pregnancy Trimester, First | 2 | 0.0 |
Pregnancy Trimester, Third | 2 | 1.0 |
Pregnancy Proteins/*analysis | 5 | 3.0 |
Tumor Necrosis Factor-alpha/*pharmacology | 2 | 0.0 |
Mutation, Missense | 2 | 0.0 |
Gene Silencing | 2 | 0.0 |
Pregnancy Proteins/*metabolism | 3 | 5.0 |
Drosophila/genetics | 2 | 1.0 |
Risk | 2 | 0.0 |
Carcinoma, Hepatocellular/metabolism | 2 | 2.0 |
Pregnancy-Specific beta 1-Glycoproteins/*analysis | 2 | 1.0 |
Protein Structure, Tertiary/genetics | 2 | 0.0 |
*Gene Expression Regulation, Enzymologic/drug effects | 2 | 4.0 |
Gene Expression Regulation, Neoplastic/*physiology | 2 | 1.0 |
Prognosis | 2 | 0.0 |
Retrospective Studies | 2 | 0.0 |
Gene Expression Regulation, Neoplastic/*genetics | 2 | 1.0 |
Transcription Factor, Sp1/chemistry/genetics/*metabolism | 2 | 28.0 |
Fibroblasts/cytology/physiology | 2 | 2.0 |
Histone Deacetylases/*metabolism | 2 | 1.0 |
